{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:43:50Z","timestamp":1792813430249,"version":"4.5.0"},"reference-count":35,"publisher":"American Association of Zoo Veterinarians","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Zoo and Wildlife Medicine"],"published-print":{"date-parts":[[2024,9,5]]},"abstract":"<jats:p>Combinations of a low dose of opioid, such as thiafentanil, and a high dose of medetomidine, are increasingly being used for immobilization of African ungulates. Both drugs can have undesirable cardiorespiratory effects. In this study we assessed whether vatinoxan, a peripherally acting alpha2\u2013adrenergic receptor antagonist, can be used to alleviate some of these effects without affecting the immobilization quality. Eight healthy, female, boma\u2013confined blesbok (Damaliscus pygargus phillipsi), weighing a mean (SDtion) of 56.8 (4.4) kg, were immobilized twice in a randomized cross\u2013over study with a 2\u2013wk washout period using (1) 0.5 mg thiafentanil + 1.5 mg medetomidine (TM), (2) TM + vatinoxan: 0.5 mg thiafentanil + 1.5 mg medetomidine + 15 mg vatinoxan per milligram medetomidine (total of 22.5 mg, administered intramuscularly at 10 min post recumbency). Heart rate, respiratory rate, rectal temperature, oxygen saturation (SpO2), arterial blood pressure, and sedation scores from 1 to 5 (1 = limited effect; 5 = excessively deep) were measured every 5 min. Arterial blood gases (PaO2 and PaCO2) were measured at 10, 15, 25, and 35 min postrecumbency and the alveolar\u2013\u2013arterial oxygen gradient (P[A\u2013a]O2) was calculated. Induction times and immobilization quality did not differ between groups. The heart rate was significantly higher and the mean arterial pressure significantly lower in blesbok after receiving vatinoxan. All animals were hypoxemic and there were no significant differences in the respiratory rates, PaO2, PaCO2, SpO2, or P(A\u2013a)O2 gradients at any time point. Although vatinoxan did not improve respiratory variables and blood oxygenation in these animals, the change in cardiovascular variables may suggest that it improves tissue perfusion, a positive outcome that requires further investigation.<\/jats:p>","DOI":"10.1638\/2023-0066","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T05:46:37Z","timestamp":1725515197000},"page":"704-712","source":"Crossref","is-referenced-by-count":3,"title":["CARDIORESPIRATORY EFFECTS OF VATINOXAN IN BLESBOK (DAMALISCUS PYGARGUS PHILLIPSI) IMMOBILIZED WITH THIAFENTANIL \u2014MEDETOMIDINE"],"prefix":"10.1638","volume":"55","author":[{"given":"Annette","family":"Roug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus P.","family":"Raath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leith R.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesel L.","family":"Laubscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1213","reference":[{"key":"29","doi-asserted-by":"publisher","unstructured":"MR. Read,  \"J Zoo Wildl Med.\"  34, \"A review of alpha2 adrenoreceptor agonists and the development of hypoxemia in domestic and wild ruminants.\" 134 (2003)","DOI":"10.1638\/1042-7260(2003)034[0134:AROAAA]2.0.CO;2"},{"key":"17","unstructured":"HH Jalanka  and BO Roeken  \"J Zoo Wildl Med.\"  21, \"The use of medetomidine, medetomidine-ketamine combinations, and atipamezole in nondomestic mammals: a review.\" 259 (1990)"},{"key":"35","doi-asserted-by":"publisher","unstructured":"H. Wickham,  \"ggplot2: elegant graphics for data analysis.\"  (2016)","DOI":"10.1007\/978-3-319-24277-4"},{"key":"1","doi-asserted-by":"crossref","unstructured":"M Adam, V Huuskonen, MR Raekallio, et al.  \"Vet J.\"  238, \"Cardiopulmonary effects of vatinoxan in sevoflurane\u2013anaesthetised sheep receiving dexmedetomidine.\" 63 (2018)","DOI":"10.1016\/j.tvjl.2018.07.007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"M Adam, J Lind\u00e9n, M Raekallio, et al.  \"J Vet Pharmacol Ther.\"  45, \"Effects of vatinoxan on xylazine\u2013induced pulmonary alterations in sheep.\" 117 (2022)","DOI":"10.1111\/jvp.13013"},{"key":"3","unstructured":"KW Clarke, CM Trim, LW Hall,  \"Veterinary anaesthesia.\"  (2014)"},{"key":"4","doi-asserted-by":"crossref","unstructured":"BV Clineschmidt, DJ Pettibone, VJ Lotti, et al.  \"J Pharmacol Exp Ther.\"  245, \"A peripherally acting alpha\u20132 adrenoceptor antagonist: L\u2013659,066.\" 32 (1988)","DOI":"10.1016\/S0022-3565(25)22301-1"},{"key":"5","unstructured":"D. Du Plessis,  \"The potential of midazolam for use as sedative for blesbok (Damaluscus pygargus phillipsi). Thesis (MScAgric.\"  (2018)"},{"key":"6","doi-asserted-by":"crossref","unstructured":"J Einwaller, LCR Meyer, U Auer, et al.  \"Vet Rec.\"  190, \"Cardiovascular effects of intravenous vatinoxan in wild boars (Sus scrofa) anaesthetised with intramuscular medetomidine-tiletamine-zolazepam.\" e835 (2021)","DOI":"10.1002\/vetr.835"},{"key":"7","doi-asserted-by":"crossref","unstructured":"J Einwaller, J Painera, M Raekallio, et al.  \"Vet Anaesth Analg.\"  47, \"Cardiovascular effects of intravenous vatinoxan (MK\u2013467) in medetomidine\u2013tiletamine\u2013zolazepam anaesthetised red deer (Cervus elaphus).\" 518 (2020)","DOI":"10.1016\/j.vaa.2019.10.011"},{"key":"8","doi-asserted-by":"publisher","unstructured":"E Gaudio, LL Laubscher, S Pfitzer, et al.  \"Vet Anaesth Analg.\"  47, \"Immobilization quality and cardiopulmonary effects of etorphine alone compared with etorphine\u2013azaperone in blesbok (Damaliscus pygargus phillipsi).\" 528 (2020)","DOI":"10.1016\/j.vaa.2019.10.012"},{"key":"10","doi-asserted-by":"crossref","unstructured":"KA Grimm, LA Lamont, WJ Tranquilli, et al.  \"Veterinary anesthesia and analgesia\u2014Lumb and Jones.\"  (2015)","DOI":"10.1002\/9781119421375"},{"key":"11","doi-asserted-by":"crossref","unstructured":"SC. Haskins,  \"Small animal critical care medicine.\"  \"Chapter 15 \u2013 Hypoxemia.\" 81 (2015)","DOI":"10.1016\/B978-1-4557-0306-7.00015-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"JM Honkavaara, MR Raekallio, PM Syrja, et al.  \"Vet Anaesth Analg.\"  47, \"Concentrations of medetomidine enantiomers and vatinoxan, an \u03b12\u2013adrenoceptor antagonist, in plasma and central nervous tissue after intravenous coadministration in dogs.\" 47 (2020)","DOI":"10.1016\/j.vaa.2019.07.004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"JM Honkavaara, F Restitutti, MR Raekallio, et al.  \"J Vet Pharmacol Ther.\"  34, \"The effects of increasing doses of MK\u2013467, a peripheral alpha(2)\u2013adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs.\" 332 (2011)","DOI":"10.1111\/j.1365-2885.2010.01242.x"},{"key":"14","unstructured":"A. Hoque,  \"Agric Rev.\"  42, \"Various systemic effects of MK\u2013467, a peripherally acting \u03b12\u2013adrenoceptor antagonist in different animal species: an overview.\" 348"},{"key":"15","doi-asserted-by":"publisher","unstructured":"ZB Ismail, K Jawasreh, A Al\u2013Majali,  \"Comp Clin Pathol.\"  19, \"Effect of xylazine\u2013ketamine\u2013diazepam anesthesia on certain clinical and arterial blood gas parameters in sheep and goats.\" 11 (2010)","DOI":"10.1007\/s00580-009-0896-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"AT Jaeger, BH Pypendop, H Ahokoivu, et al.  \"Vet Anaesth Analg.\"  46, \"Cardiopulmonary effects of dexmedetomidine, with and without vatinoxan, in isoflurane\u2013anesthetized cats.\" 753 (2019)","DOI":"10.1016\/j.vaa.2019.05.012"},{"key":"18","unstructured":"A. Kassambara,  \"Rstatix: Pipe\u2013friendly framework for basic statistical tests.\"  (2021)"},{"key":"19","doi-asserted-by":"crossref","unstructured":"SBR. K\u00e4stner,  \"Vet Anaesth Analg.\"  33, \"Alpha2\u2013agonists in sheep: a review.\" 79 (2006)","DOI":"10.1111\/j.1467-2995.2005.00243.x"},{"key":"20","unstructured":"MD Kock  and R. Burroughs  \"Chemical and physical restraint of African wild animals.\"  2021"},{"key":"21","doi-asserted-by":"crossref","unstructured":"R Kumar, M Singh, NK Verma, et al.  \"Indian J Anim Res.\"  54, \"Systemic effects and clinical application of medetomidine in animals: a review.\" 1063 (2020)","DOI":"10.18805\/ijar.B-3864"},{"key":"22","doi-asserted-by":"crossref","unstructured":"LL Laubscher, LCR Meyer, M Laurence, et al.  \"J S Afr Vet Assoc.\"  93, \"A comparison of immobilisation quality and cardiorespiratory effects of etorphine-azaperone versus etorphine-midazolam combinations in blesbok.\" 1 (2022)","DOI":"10.36303\/JSAVA.2022.93.1.491"},{"key":"23","doi-asserted-by":"crossref","unstructured":"LCR Meyer, RS Hetem, D Mitchell, et al.  \"BMC Vet Res.\"  11, \"Hypoxia following etorphine administration in goats (Capra hircus) results more from pulmonary hypertension than from hypoventilation.\" 1 (2015)","DOI":"10.1186\/s12917-015-0337-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"S Neudeck, L Twele, V Kopp, et al.  \"J Vet Pharmacol Ther.\"  44, \"Pharmacodynamics and plasma concentrations of dexmedetomidine with or without vatinoxan as a constant-rate infusion in horses anaesthetized with isoflurane\u2014a pilot study.\" 754 (2021)","DOI":"10.1111\/jvp.12992"},{"key":"25","doi-asserted-by":"crossref","unstructured":"L Niemann, APN Kutter, FB Joerger, et al.  \"Vet Anaesth Analg.\"  49, \"The impact of vatinoxan on microcirculation after intramuscular co-administration with medetomidine in Beagle dogs: a blinded crossover study.\" 336 (2022)","DOI":"10.1016\/j.vaa.2021.07.007"},{"key":"26","doi-asserted-by":"crossref","unstructured":"S Pfitzer, M Laurence, LL Laubscher, et al.  \"J S Afr Vet Assoc.\"  91, \"Do potent immobilising\u2013opioids induce different physiological effects in impala and blesbok?\" 1 (2020)","DOI":"10.4102\/jsava.v91i0.2038"},{"key":"28","doi-asserted-by":"crossref","unstructured":"MR Raekallio, JM Honkavaara, OM Vainio,  \"J Vet Pharmacol Ther.\"  33, \"The effects of L\u2013659,066, a peripheral \u03b12\u2013adrenoceptor antagonist, and verapamil on the cardiovascular influences of dexmedetomidine in conscious sheep.\" 434 (2010)","DOI":"10.1111\/j.1365-2885.2009.01156.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"F Restitutti, JM Honkavaara, MR Raekallio, et al.  \"Vet Anaesth Analg.\"  38, \"Effects of different doses of L\u2013659'066 on the bispectral index and clinical sedation in dogs treated with dexmedetomidine.\" 415 (2011)","DOI":"10.1111\/j.1467-2995.2011.00630.x"},{"key":"31","unstructured":"A Roug, C Smith, J Raath, et al.  \"J S Afr Vet Assoc.\"  94, \"Efficacy and safety of three different opioid\u2013based immobilisation combinations in blesbok (Damaliscus pygargus phillipsi).\" 145 (2023)"},{"key":"32","doi-asserted-by":"crossref","unstructured":"S Sainmaa, A Mykk\u00e4nen, M Adam, et al.  \"J Zoo Wildl Med.\"  50, \"Intravenous vatinoxan in markhors (Capra falconeri heptneri) immobilized with intramuscular medetomidine and ketamine\u2013\u2014a preliminary dose screening study.\" 159 (2019)","DOI":"10.1638\/2018-0030"},{"key":"33","unstructured":"H. Tapio,  \"Impact of vatinoxan on cardiopulmonary and gastrointestinal effects of medetomidine and detomidine in horses.\"  (2020)"},{"key":"34","doi-asserted-by":"crossref","unstructured":"G West, D Heard, N Caulkett,  \"Zoo animal and wildlife immobilization and anaesthesia.\"  (2007)","DOI":"10.1002\/9780470376478"},{"key":"9","doi-asserted-by":"crossref","unstructured":"EM Greunz, D Lim\u00f3n, RL Petersen, et al.  \"Vet Anaesth Analg.\"  48, \"The impact of vatinoxan on medetomidine\u2013ketamine\u2013midazolam immobilization in Patagonian maras (Dolichotis patagonum).\" 372 (2021)","DOI":"10.1016\/j.vaa.2020.08.012"},{"key":"27","unstructured":"LP. Posner,  \"Veterinary pharmacology and therapeutics.\"  \"Chapter 14. Sedatives and tranquilizers.\" 324 (2018)"}],"container-title":["Journal of Zoo and Wildlife Medicine"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:17:53Z","timestamp":1791245873000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/journal-of-zoo-and-wildlife-medicine\/volume-55\/issue-3\/2023-0066\/CARDIORESPIRATORY-EFFECTS-OF-VATINOXAN-IN-BLESBOK-DAMALISCUS-PYGARGUS-PHILLIPSI-IMMOBILIZED\/10.1638\/2023-0066.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1638\/2023-0066","relation":{},"ISSN":["1042-7260","1937-2825"],"issn-type":[{"value":"1042-7260","type":"print"},{"value":"1937-2825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]}}}